Successful golimumab therapy in four patients with refractory Takayasu’s arteritis

Rie Suematsu, Satoko Tashiro, Nobuyuki Ono, Syuichi Koarada, Akihide Ohta, Yoshifumi Tada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Recent studies suggested that anti-TNF-α biological therapies are effective in treating Takayasu's arteritis (TA) refractory to conventional immunosuppressive therapy. However, the efficacy of golimumab (GLM) for TA therapy is unknown. We report four women with TA who were successfully treated with GLM. GLM was prescribed as induction therapy for three patients and as maintenance therapy for one patient. GLM showed therapeutic value and might be useful, together with other anti-TNF-α agents, in treating TA.

Original languageEnglish
Pages (from-to)712-715
Number of pages4
JournalModern Rheumatology
Volume28
Issue number4
DOIs
Publication statusPublished - Jul 4 2018
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Rheumatology

Fingerprint Dive into the research topics of 'Successful golimumab therapy in four patients with refractory Takayasu’s arteritis'. Together they form a unique fingerprint.

  • Cite this